Showing results (41-50 of 298) with videos related to

Sort By:
Pageof 30
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2005
[Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)']Osamu Maeda, Michiyuki Usami
Molecular and Clinical Oncology|March 17, 2023
Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancerYao Liang, Osamu Maeda, Kazushi Miyata, et al.
International Cancer Conference Journal|July 23, 2026
Severe nail toxicity induced by FGFR inhibitor in FGFR2-rearranged cholangiocarcinomaChiaki Kondo, Ayako Mitsuma, Yuichi Ando
International Journal of Environmental Research and Public Health|December 8, 2023
Long- and Short-Term Trends in Outpatient Attendance by Speciality in Japan: A Joinpoint Regression Analysis in the Context of the COVID-19 PandemicAsuka Takeda, Yuichi Ando, Jun Tomio
Investigational New Drugs|November 4, 2005
Pharmacogenetics of irinotecan: a promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecanMaki Ando, Yoshinori Hasegawa, Yuichi Ando
Expert Review of Molecular Diagnostics|July 11, 2006
Screening for adverse reactions to irinotecan treatment using the Invader UGT1A1 Molecular AssayYoshinori Hasegawa, Yuichi Ando, Kaoru Shimokata
International Journal of Clinical Oncology|August 10, 2017
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in JapanSachi Morita, Toyone Kikumori, Nobuyuki Tsunoda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Thalidomide metabolism by the CYP2C subfamilyYuichi Ando, Eiichi Fuse, William D Figg
Pageof 30